当前位置:首页 - 行情中心 - 百诚医药(301096) - 财务分析

百诚医药

(301096)

  

流通市值:48.96亿  总市值:64.60亿
流通股本:8278.72万   总股本:1.09亿

百诚医药(301096)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.03亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益258245.78万元,未分配利润36197.36万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产387494.03万元,负债129248.25万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入332,353,112.78128,727,480.49801,923,244.22721,478,652.99
营业总成本336,557,099.34164,765,613.68809,886,835.1580,693,571.16
其他经营收益
营业利润3,685,713.16-27,913,185.92-34,393,587.84130,833,977.21
利润总额3,900,486.09-27,784,050.64-36,060,972.55130,715,405.62
净利润3,098,160.54-26,197,617.81-52,922,991.09141,537,618.64
每股收益
其他综合收益-30,111.11-32,349.31-6,882.642,248.55
综合收益总额3,068,049.43-26,229,967.12-52,929,873.73141,539,867.19
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,732,648,797.081,610,431,297.781,545,474,358.291,591,071,868.79
非流动资产:
非流动资产合计2,142,291,514.812,163,454,579.032,175,714,157.212,168,831,814.19
资产总计3,874,940,311.893,773,885,876.813,721,188,515.53,759,903,682.98
流动负债:
流动负债合计951,870,447846,593,327.09769,379,232.56821,900,623.85
非流动负债:
非流动负债合计340,612,031.18374,132,732.56372,419,498.66167,899,305.37
负债合计1,292,482,478.181,220,726,059.651,141,798,731.22989,799,929.22
所有者权益(或股东权益):
归属于母公司股东权益合计2,582,457,833.712,553,159,817.162,579,389,784.282,769,732,268.46
股东权益合计2,582,457,833.712,553,159,817.162,579,389,784.282,770,103,753.76
负债和股东权益合计3,874,940,311.893,773,885,876.813,721,188,515.53,759,903,682.98
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计211,529,707.21108,725,148.09652,039,793.93476,014,362.72
经营活动现金流出小计325,948,946.26178,755,029.29847,896,719.57659,069,923.64
经营活动产生的现金流量净额-114,419,239.05-70,029,881.2-195,856,925.64-183,055,560.92
投资活动产生的现金流量:
投资活动现金流入小计238,640,556.86128,032,273.42472,533,753.97205,598,029.65
投资活动现金流出小计374,813,468.47216,818,178.62937,071,213.72769,026,433.85
投资活动产生的现金流量净额-136,172,911.61-88,785,905.2-464,537,459.75-563,428,404.2
筹资活动产生的现金流量:
筹资活动现金流入小计510,000,000200,000,0001,253,720,662.98673,783,342.98
筹资活动现金流出小计276,094,193.7884,345,847.91955,630,611.49480,411,888.06
筹资活动产生的现金流量净额233,905,806.22115,654,152.09298,090,051.49193,371,454.92
汇率变动对现金及现金等价物的影响326,514.9-30,408.9112,965.021,720.59
现金及现金等价物净增加额-16,359,829.54-43,192,043.22-362,291,368.88-553,110,789.61
期末现金及现金等价物余额399,801,516.52372,969,302.84416,161,346.06225,341,925.33
补充资料:
现金及现金等价物的净增加额-16,359,829.54--362,291,368.88-
最新报告期:2025-09-02
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华鑫证券胡博新0.430.590.942025-09-02
太平洋周豫0.760.810.952025-08-26
TOP↑